|
|
Volumn 8, Issue 4, 2012, Pages 20-27
|
|
Critical limb ischemia: cell and molecular therapies for limb salvage.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMPUTATION;
ANGIOGENESIS;
BIOLOGICAL THERAPY;
CELL THERAPY;
CRITICAL LIMB ISCHEMIA;
FIBROBLAST GROWTH FACTOR (FGF);
GENE THERAPY;
HEPATOCYTE GROWTH FACTOR (HGF);
HUMAN;
ISCHEMIA;
LEG;
LIMB SALVAGE;
METHODOLOGY;
MOLECULAR THERAPY;
MOLECULARLY TARGETED THERAPY;
REVIEW;
THERAPEUTIC ANGIOGENESIS;
VASCULAR ENDOTHELIAL CELL GROWTH FACTOR (VEGF);
VASCULARIZATION;
AMPUTATION;
ARTERIOGENESIS;
CELL THERAPY;
CRITICAL LIMB ISCHEMIA;
FIBROBLAST GROWTH FACTOR (FGF);
GENE THERAPY;
HEPATOCYTE GROWTH FACTOR (HGF);
LIMB SALVAGE;
MOLECULAR THERAPY;
THERAPEUTIC ANGIOGENESIS;
VASCULAR ENDOTHELIAL CELL GROWTH FACTOR (VEGF);
VASCULOGENESIS;
HUMANS;
ISCHEMIA;
LEG;
LIMB SALVAGE;
MOLECULAR TARGETED THERAPY;
TISSUE THERAPY;
MLCS;
MLOWN;
|
|
EID: 84879547051
PISSN: None
EISSN: 19476108
Source Type: None
DOI: 10.14797/mdcj-8-4-20 Document Type: Review |
|
Times cited : (26)
|
|
References (0)
|
